Literature DB >> 7819014

Viral hepatitis in children with renal disease.

G V Gregorio1, A P Mowat.   

Abstract

Specific and sensitive diagnostic tests are now available to identify type A, B, C, D and E hepatitis. Hepatitis A and E which cause only acute, very rarely fulminant, hepatitis are spread largely by the faecal-oral route, having a brief viraemic phase. Hepatitis B, C and D which are transmitted parenterally and via secretions are often associated with chronic viraemia. Patients with chronic renal disease are at particular risk. Impaired immunity due to disease or drugs increases the propensity to develop a chronic carrier state which may progress to cirrhosis and hepatocellular carcinoma. Limited reports indicate that hepatitis C infection may cause cirrhosis more rapidly than hepatitis B. The emergence of mutants to both hepatitis B and C is a cause for concern. Treatment with interferon is of limited efficacy. Screening of blood products for viral markers and prudent handling of potentially infected materials to avoid contamination of damaged skin or mucous membrane are the best strategies to prevent infection. Hepatitis B vaccination of all newborns, young adolescents and those at risk is the most effective means of reducing the carrier frequency.

Entities:  

Mesh:

Year:  1994        PMID: 7819014     DOI: 10.1007/bf00858146

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  90 in total

Review 1.  Delta hepatitis. The disease and the virus.

Authors:  J P Monjardino; J A Saldanha
Journal:  Br Med Bull       Date:  1990-04       Impact factor: 4.291

2.  Long-term evolution of chronic hepatitis B in children with antibody to hepatitis B e antigen.

Authors:  F Bortolotti; R Calzia; P Cadrobbi; C Crivellaro; A Alberti; M G Marazzi
Journal:  J Pediatr       Date:  1990-04       Impact factor: 4.406

3.  Prospective, randomized controlled trial of interferon-alpha in children with chronic hepatitis B.

Authors:  M Ruiz-Moreno; M J Rua; J Molina; G Moraleda; A Moreno; J García-Aguado; V Carreño
Journal:  Hepatology       Date:  1991-06       Impact factor: 17.425

4.  Hepatitis C markers in hemodialysis patients.

Authors:  C S Huang; M S Ho; C S Yang; C L Lee; C A Tan
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

5.  Interferon treatment for hepatitis B-associated membranous glomerulonephritis in two Chinese children.

Authors:  S N Wong; E C Yu; A S Lok; K W Chan; Y L Lau
Journal:  Pediatr Nephrol       Date:  1992-09       Impact factor: 3.714

6.  Hepatitis in children with thalassemia major.

Authors:  G Nigro; G Taliani; U Bartmann; R Vitolo; T Perrone; S Mattia; P Pisano; A Petruccelli; S Maiozzi; M Midulla
Journal:  Arch Virol Suppl       Date:  1992

7.  Liver cirrhosis associated with chronic hepatitis B virus infection in childhood.

Authors:  F Bortolotti; R Calzia; P Cadrobbi; R Giacchini; B Ciravegna; M Armigliato; R Piscopo; G Realdi
Journal:  J Pediatr       Date:  1986-02       Impact factor: 4.406

8.  Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children.

Authors:  R Goldsmith; P O Yarbough; G R Reyes; K E Fry; K A Gabor; M Kamel; S Zakaria; S Amer; Y Gaffar
Journal:  Lancet       Date:  1992-02-08       Impact factor: 79.321

9.  Hepatitis B surface antigenemia in North American children with membranous glomerulonephropathy. Southwest Pediatric Nephrology Study Group.

Authors: 
Journal:  J Pediatr       Date:  1985-04       Impact factor: 4.406

10.  Seroprevalence of anti-HCV in an urban child population: a pilot survey in a developing area, Cameroon.

Authors:  T Ngatchu; T Stroffolini; M Rapicetta; P Chionne; D Lantum; M Chiaramonte
Journal:  J Trop Med Hyg       Date:  1992-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.